CBT

Cabot Corp. 10-Q Summary: Quarter Ended December 31, 2001

Business Context and Reporting Period

This is an unaudited Quarterly Report (Form 10-Q) for Cabot Corporation, a Delaware corporation, for the three-month period ended December 31, 2001 (First Quarter of Fiscal 2002). The company operates in three primary segments: Chemical Businesses, Performance Materials, and Specialty Fluids.

Key Financial Metrics

Material Changes vs. Prior Period

• Profitability Improvement: Despite a 5% decline in net sales ($18 million decrease), net income increased 36% ($10 million) and operating profit before taxes rose 41% to $52 million. This was driven by lower raw material costs (oil-based feedstock and natural gas) and favorable product mix shifts.
• Segment Performance:
  • Chemical Businesses: Sales fell 12% and operating profit dropped 34% due to significant volume declines in carbon black (global volumes down 11%) and fumed metal oxides (volumes down 15%).
  • Performance Materials: Sales surged 46% to $82 million, and operating profit jumped $34 million. This was due to higher average selling prices (up 57%) and lower costs, despite an 8% volume decline in tantalum products.
  • Specialty Fluids: Sales increased to $9 million with flat operating profit of $1 million.
• Cash Flow: Operating cash outflow improved significantly from $214 million in the prior year to $6 million, largely because the prior year included a massive tax payment related to the 2000 disposition of the Liquefied Natural Gas business.
• Capital Structure: The company repurchased $16 million of common stock and $3 million of preferred stock. Total debt-to-capital increased from 9% to 14%.

Guidance, Outlook, and Risks

• Outlook: Management remains cautious regarding the Chemical Businesses due to weak volumes and market uncertainty. For Performance Materials, the outlook is also cautious; while the industry downturn may have bottomed out, high inventory levels in the supply chain and customer contract disputes regarding volume timing create uncertainty for the remainder of the fiscal year.
• Capital Expenditures: Expected to be $280-$300 million for fiscal 2002, including a $100 million buyout of the partner in the Showa Cabot Supermetals joint venture.
• Subsequent Event: On February 8, 2002, Cabot purchased the remaining 50% of Showa Cabot Supermetals KK for approximately $100 million plus the assumption of $100 million in debt.
• Contingencies:
  • Respirator Litigation: Cabot indemnifies a former business unit for asbestos/silicosis claims. While new case filings increased, the rate decreased in late 2001. Management believes pending suits will not have a material aggregate effect, though a remote possibility of material adverse impact exists.
  • Environmental: Approximately $29 million is reserved for environmental matters related to divested businesses.
• Accounting Changes: Cabot adopted FAS No. 142 (Goodwill) on October 1, 2001, ceasing goodwill amortization. No impairments were found upon adoption. The company is evaluating the impact of FAS No. 143 (Asset Retirement Obligations) and FAS No. 144 (Impairment/Disposal), effective October 1, 2002.

Investor Verification Checklist

• Verify the sustainability of the 46% sales increase in Performance Materials given the noted inventory overhang and customer contract disputes regarding volume timing.
• Monitor the resolution of the Showa Cabot Supermetals joint venture buyout and the integration of the $100 million debt assumption.
• Review the status of respirator litigation claims to ensure the "remote possibility" of material impact remains valid as new cases are filed.
• Assess the impact of the $100 million capital expenditure for the joint venture buyout on future liquidity and debt ratios.
• Confirm whether the volume declines in the Chemical Businesses (Carbon Black and Fumed Metal Oxides) represent a temporary market fluctuation or a structural shift in demand.